Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism
- PMID: 10406988
- PMCID: PMC1736478
- DOI: 10.1136/jnnp.67.2.195
Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism
Abstract
Objectives: Mutational analysis of the sterol 27-hydroxylase (CYP27) gene was performed on three patients from two Japanese families who had cerebrotendinous xanthomatosis (CTX) associated with parkinsonism.
Methods: Clinical evaluations, brain MRI studies, and laboratory analyses were completed on the three patients. The CYP27 gene was analysed for mutations by PCR amplification of gene segments followed by direct sequencing.
Results: Two different, homozygous mutations were identified in these families. One is a novel transition, substituting T for G at Glu162 (GAG) resulting in a stop codon (TAG). The other is also a transition, substituting T for C at Arg441 (CGG) resulting in Trp (TGG). The second is located in two amino acids ahead of the heme ligand binding site (Cys443) of the protein likely rendering it non-functional. It is the most common CTX mutation in Japanese patients.
Conclusions: CTX with parkinsonism is caused by mutations with a severe impact on enzyme function. The two mutations described here are likely to cause loss of function because they are chain terminating or affect an essential site in the protein.
Similar articles
-
Identification of new mutations in sterol 27-hydroxylase gene in Japanese patients with cerebrotendinous xanthomatosis (CTX).J Lipid Res. 1994 Jun;35(6):1031-9. J Lipid Res. 1994. PMID: 7915755
-
A novel mutation in the sterol 27-hydroxylase gene of a Pakistani family with autosomal recessive cerebrotendinous xanthomatosis.Neurology. 1997 Jan;48(1):258-60. doi: 10.1212/wnl.48.1.258. Neurology. 1997. PMID: 9008528
-
Novel homozygous and compound heterozygous mutations of sterol 27-hydroxylase gene (CYP27) cause cerebrotendinous xanthomatosis in three Japanese patients from two unrelated families.J Lipid Res. 1997 May;38(5):870-9. J Lipid Res. 1997. PMID: 9186905
-
Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.Neurol Sci. 2006 Jun;27(2):143-9. doi: 10.1007/s10072-006-0618-7. Neurol Sci. 2006. PMID: 16816916 Review.
-
Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans.Trends Endocrinol Metab. 2000 Jul;11(5):180-3. doi: 10.1016/s1043-2760(00)00255-1. Trends Endocrinol Metab. 2000. PMID: 10856919 Review.
Cited by
-
Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.J Atheroscler Thromb. 2021 Sep 1;28(9):905-925. doi: 10.5551/jat.RV17055. Epub 2021 May 8. J Atheroscler Thromb. 2021. PMID: 33967188 Free PMC article.
-
Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.J Inherit Metab Dis. 2018 Jul;41(4):647-656. doi: 10.1007/s10545-018-0152-9. Epub 2018 Feb 26. J Inherit Metab Dis. 2018. PMID: 29484516 Review.
-
Case report: Cerebrotendinous xanthomatosis with a novel mutation in the CYP27A1 gene mimicking behavioral variant frontotemporal dementia.Front Neurol. 2023 Mar 7;14:1131888. doi: 10.3389/fneur.2023.1131888. eCollection 2023. Front Neurol. 2023. PMID: 36959818 Free PMC article.
-
Systematic Review of Parkinsonism in Cerebrotendinous Xanthomatosis.Neurol Int. 2025 Jul 30;17(8):117. doi: 10.3390/neurolint17080117. Neurol Int. 2025. PMID: 40863986 Free PMC article. Review.
-
Movement disorders and inborn errors of metabolism in adults: a diagnostic approach.J Inherit Metab Dis. 2008 Jun;31(3):308-18. doi: 10.1007/s10545-008-0854-5. Epub 2008 May 30. J Inherit Metab Dis. 2008. PMID: 18563632 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical